ISTA Pharma (ISTA) Pops 66%+ Following Valeant (VRX) Proposal
Tweet
Share
E-mailGet Alerts ISTA Hot Sheet
Join SI Premium – FREE
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), shares up over 66 percent following $6.50 per share proposal from Valeant (NYSE: VRX).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carlyle to sell Copia Power to EQT - FT
- FCPT acquires Gerber Collision property in Texas for $4.8M
- Steel Partners offers $16.75 per share to acquire InMode
Create E-mail Alert Related Categories
Insiders' Blog, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
